Sugammadex Versus Neostigmine for Reversal of Rocuronium-induced Neuromuscular Blockade: A Study of Thoracic Surgical Patients
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2018
At a glance
- Drugs Sugammadex (Primary) ; Glycopyrrolate; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 09 Oct 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Jun 2019.
- 30 Oct 2017 Status changed from not yet recruiting to recruiting.
- 02 Jun 2017 New trial record